Current stock page

Catalysts

PRAX Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

PRAXPraxis Precision Medicines, Inc.

Healthcare / Biotechnology

Relative Leader / Watch

Strong Relative Position

NeutralEdge 9/10
$328.13+$3.37 (+1.04%)

Latest quote

  • Momentum
    48
  • Value
    —
  • Quality
    72
  • Risk resilience
    47
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 18, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 57/100

Momentum 48/100 and sentiment — before the next covered event.

Recent coverage
4 articles

Updated Nov 15, 2026 · Sentiment 14.84%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 48/100AIQ Edge 9/10 Strong Relative Position
Beat rate
63%
5 of 8 reported periods
Average surprise
+3.1%
Across covered historical reports
Latest result
+8.8%
Nov 9, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 9, 2026—-$3.54-$3.23+8.8%$130.77K—
Aug 6, 2026—-$3.67-$2.87+21.8%$1.25M—
May 7, 2026—-$3.58-$3.20+10.6%$100K—
Feb 19, 2026—-$3.13-$3.50-12.0%$66.67K—
Nov 5, 2025—-$3.45-$3.36+2.6%$256.09K—
Aug 4, 2025—-$3.40-$3.31+2.6%$59.44K—
May 2, 2025—-$3.20-$3.29-2.8%$198.8K—
Feb 28, 2025—-$2.76-$2.94-6.5%$297.88K$7.46M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
19
Buy
1
Hold
1
Sell
12-month analyst target
$660.33
+101.24% versus current price
Based on 21 analyst observations. Targets are estimates, not predictions.
Low target
$575.00
+75.24% vs latest price
Average target
$660.33
+101.24% vs latest price
High target
$706.00
+115.16% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 18, 2027

Next known earnings or reporting date.

EPS estimate-$4.08

Current analyst expectation for the upcoming report.

Revenue estimate$375.15K

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score48

Where event reaction would show up first.

AIQ score57/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
21
Average target
$660.33
Target upside
101.24%
Target range
$575.00 - $706.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
3
Neutral
0
Negative
1
seekingalpha.com · Nov 11, 2026

Praxis Precision Medicines, Inc. (PRAX) Presents at 3rd Annual Guggenheim Healthcare Innovation Conference Transcript

Praxis Precision Medicines, Inc. (PRAX) 3rd Annual Guggenheim Healthcare Innovation Conference November 9, 2026 9:30 AM ESTCompany ParticipantsMarcio Souza...

gurufocus.com · Nov 9, 2026

PRAX Reiterated by BTIG -- Price Target Maintained at $826

Praxis Precision Medicine (PRAX) Analyst Rating Update On October 03, 2023, BTIG reaffirmed its "Buy" rating for Praxis Precision Medicine (PRAX) and maintai

gurufocus.com · Oct 16, 2026

PRAX Initiated Coverage by JP Morgan -- Rating Set to Overweight

Praxis Precision Medicine (PRAX) Analyst Rating Update On October 15, 2026, JP Morgan initiated coverage on Praxis Precision Medicine (PRAX) with an Overweig

gurufocus.com · Oct 15, 2026

PRAX Initiated Coverage by UBS -- Price Target Announced at $706

Praxis Precision Medicine (PRAX) Analyst Rating Update On October 6, 2026, Praxis Precision Medicine (PRAX) has garnered attention today as UBS initiates cov

Open full news and sentiment

PRAX Catalysts FAQ

What are the next catalysts for PRAX stock?

PRAX's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move PRAX stock?

Upcoming events that could move PRAX include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could PRAX's next earnings report affect the stock?

PRAX's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive PRAX stock higher?

PRAX could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt PRAX stock?

PRAX could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.